Addex Therapeutics (Switzerland) Analysis
| ADXN Stock | CHF 0.06 0.0008 1.27% |
Addex Therapeutics is overvalued with Real Value of 0.0554 and Hype Value of 0.06. The main objective of Addex Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Addex Therapeutics is worth, separate from its market price. There are two main types of Addex Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Addex Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Addex Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Addex Therapeutics stock is traded in Switzerland on SIX Swiss Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Switzerland. Addex Therapeutics is usually not traded on National Day, Christmas Day, St . Stephen 's Day, New Year 's Day, Berchtoldstag, Good Friday, Easter Monday, International Workers ' Day. Addex Stock trading window is adjusted to Europe/Zurich timezone.
Addex |
Addex Stock Analysis Notes
The company has price-to-book (P/B) ratio of 1.62. Some equities with similar Price to Book (P/B) outperform the market in the long run. Addex Therapeutics recorded a loss per share of 0.53. The entity last dividend was issued on the 26th of July 2022. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Plan-les-Ouates, Switzerland. ADDEX N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 17 people. For more info on Addex Therapeutics please contact Timothy Dyer at (41) 22 884 15 56 or go to www.addexpharma.com.Addex Therapeutics Investment Alerts
| Addex Therapeutics generated a negative expected return over the last 90 days | |
| Addex Therapeutics has high historical volatility and very poor performance | |
| Addex Therapeutics has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.92 M. Net Loss for the year was (15.35 M) with loss before overhead, payroll, taxes, and interest of (9.69 M). | |
| Addex Therapeutics has accumulated about 20.48 M in cash with (14.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Addex Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 28.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Addex Therapeutics's market, we take the total number of its shares issued and multiply it by Addex Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 30th of November, Addex Therapeutics shows the risk adjusted performance of (0.02), and Mean Deviation of 3.91. Addex Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Addex Therapeutics mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Addex Therapeutics is priced correctly, providing market reflects its regular price of 0.062 per share.Addex Therapeutics Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Addex Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Addex Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Addex Therapeutics Outstanding Bonds
Addex Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Addex Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Addex bonds can be classified according to their maturity, which is the date when Addex Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Addex Therapeutics Predictive Daily Indicators
Addex Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Addex Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 21904.55 | |||
| Daily Balance Of Power | (0.21) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.0601 | |||
| Day Typical Price | 0.0607 | |||
| Price Action Indicator | 0.0015 | |||
| Period Momentum Indicator | (0.0008) | |||
| Relative Strength Index | 45.69 |
Addex Therapeutics Forecast Models
Addex Therapeutics' time-series forecasting models are one of many Addex Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Addex Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Addex Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Addex Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Addex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Addex Therapeutics. By using and applying Addex Stock analysis, traders can create a robust methodology for identifying Addex entry and exit points for their positions.
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Plan-les-Ouates, Switzerland. ADDEX N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 17 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Addex Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Additional Tools for Addex Stock Analysis
When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.